Published 19 days ago

Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson

A federal judge in New Jersey rejected legal challenges from Johnson & Johnson and Bristol Myers Squibb to the Biden administration's Medicare drug price negotiations, ruling the program constitutional.
This ruling stands as a victory for the Biden administration amidst legal disputes with drugmakers over price negotiations strategy.
President Biden's Inflation Reduction Act includes the Medicare drug price negotiations to make expensive medications more affordable for seniors, potentially impacting drugmakers' profits.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Reuters

J&J, Bristol Myers lose challenges to US drug price negotiation program

A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

19 days ago·United Kingdom

Read Full Article

CNBC

Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations

The decision is another win for the Biden administration in a bitter legal fight with several drugmakers over the constitutionality of the price talks.

20 days ago·United States

Read Full Article

The Hill

Judge tosses Medicare drug negotiation challenges from Bristol Myers Squibb, Johnson & Johnson

A federal judge on Monday threw out legal challenges to the Medicare negotiation program that had been brought by Bristol Myers Squibb and Johnson & Johnson, finding that their claims of unconstitutionality do not hold up. In their two separate lawsuits, both Bristol Myers Squibb and Johnson & Johnson allege that the Medicare negotiation program…

19 days ago·Washington, United States

Read Full Article

Devdiscourse

J&J, Bristol Myers lose challenges to US drug price negotiation program

J&J, Bristol Myers lose challenges to US drug price negotiation program A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.U.S. District Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge to uphold the p…

20 days ago

Read Full Article

WTVB

J&J, Bristol Myers lose challenges to US drug price negotiation program

By Brendan Pierson (Reuters) – A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government’s Medicare health insurance program or pay heavy penalties. U.S. District Judge Zahid Quraishi in Trenton, New Jersey, became the fourth federal judge to uphold the program, one of Democratic President J…

20 days ago

Read Full Article

New Hampshire Union Leader

J&J, Bristol Myers lose challenges to drug price negotiation program

A judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or…

20 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year